0001144204-12-007742.txt : 20120213 0001144204-12-007742.hdr.sgml : 20120213 20120213162430 ACCESSION NUMBER: 0001144204-12-007742 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20120213 DATE AS OF CHANGE: 20120213 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Sarvazyan Armen CENTRAL INDEX KEY: 0001488261 FILING VALUES: FORM TYPE: SC 13G MAIL ADDRESS: STREET 1: 1753 LINVALE-HARBOURTON ROAD CITY: LAMBERTVILLE STATE: NJ ZIP: 08530 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ProUroCare Medical Inc. CENTRAL INDEX KEY: 0001222244 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 201212923 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-81640 FILM NUMBER: 12599418 BUSINESS ADDRESS: STREET 1: 6440 FLYING CLOUD DRIVE STREET 2: SUITE 101 CITY: EDEN PRAIRIE STATE: MN ZIP: 55344 BUSINESS PHONE: 952-698-1161 MAIL ADDRESS: STREET 1: 6440 FLYING CLOUD DRIVE STREET 2: SUITE 101 CITY: EDEN PRAIRIE STATE: MN ZIP: 55344 FORMER COMPANY: FORMER CONFORMED NAME: ProUroCare DATE OF NAME CHANGE: 20041004 FORMER COMPANY: FORMER CONFORMED NAME: GLOBAL INTERNET COMMUNICATIONS INC DATE OF NAME CHANGE: 20030310 SC 13G 1 v302417_sc13g.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) ProUroCare Medical Inc. (Name of Issuer) Common Stock, par value $0.00001 per share COMMON STOCK (Title of Class of Securities) 74373C 10 7 (CUSIP Number) February 13, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: /_/ Rule 13d-1(b) /X/ Rule 13d-1(c) /_/ Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 74373C 10 7 CUSIP No. -------------------------------------------------------------------------------- 1) Names of Reporting Persons. Armen Sarvazyan I.R.S. Identification Nos. of Above Persons (entities only) -------------------------------------------------------------------------------- 2) Check the Appropriate Box if a Member of a Group (a) [ ] (See Instructions) (b) [ ] -------------------------------------------------------------------------------- 3) SEC Use Only -------------------------------------------------------------------------------- 4) Citizenship or Place of Organization United States -------------------------------------------------------------------------------- Number of Shares 5) Sole Voting Power 867,878 Beneficially --------------------------------------------------- Owned by Each 6) Shared Voting Power 140,386 Reporting --------------------------------------------------- Person With 7) Sole Dispositive Power 867,878 --------------------------------------------------- 8) Shared Dispositive Power 140,386 -------------------------------------------------------------------------------- 9) Aggregate Amount Beneficially Owned by Each Reporting Person 998,264 -------------------------------------------------------------------------------- 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) NA [ ] -------------------------------------------------------------------------------- 11) Percent of Class Represented by Amount in Item 9 6% -------------------------------------------------------------------------------- 12) Type of Reporting Person (See Instructions) IN -------------------------------------------------------------------------------- ITEM 1. (A) NAME OF ISSUER ProUroCare Medical Inc. (B) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICE 6440 Flying Cloud drive, STE101, Eden Prairie, MN 55344 ITEM 2. (A) NAME OF PERSONS FILING Armen Sarvazyan (B) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR IF NONE, RESIDENCE 1753 Linvale-Harbourton Rd. Lambertville, NJ 08530 (C) CITIZENSHIP United States (D) TITLE OF CLASS OF SECURITIES Common Stock, par value $0.00001 per share (E) CUSIP NUMBER 74373C 10 7 ITEM 3. If this statement is filed pursuant to rule 240.13d- 1(b), or 240.13d-2(b) or (c), check whether the person filing is a: NA (a) ___ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) ___ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) ___ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) ___ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) ___ An investment adviser in accordance with 240.13d- 1(b)(1)(ii)(E). (f) ___ An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F). (g) ___ A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G) (h) ___ A savings association as defined in section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). (i) ___ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3). (j) ___ Group, in accordance with section 240.13d-1(b)(1)(ii)(J). ITEM 4. OWNERSHIP. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 998,264 (b) Percent of class: 6% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 867,878 (ii) Shared power to vote or to direct the vote: 140,386 (iii) Sole power to dispose or to direct the disposition of: 867,878 (iv) Shared power to dispose or to direct the disposition of: 140,386 Of the total securities reported, 122,386 represent common shares and 18,000 represent warrants currently exercisable that are owned by Artann Laboratories Inc. of which Armen Sarvazyan is a minority shareholder and an officer. ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS NA If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following /___/. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON NA ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY NA ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP NA ITEM 9. NOTICE OF DISSOLUTION OF GROUP NA ITEM 10. CERTIFICATION. By signing below we certify that, to the best of our knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Dated: February 13, 2012 By: /s/ Armen Sarvazyan ---------------------------- Name: Armen Sarvazyan Title: